Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Epigenetics and Nuclear Signaling

Human LEF1 knockout Jurkat cell line (ab277910)

Description:
Human LEF1 knockout Jurkat cell line
Application:
Reactivity:
Conjugate:

Human PARP1 knockout A549 cell line (ab276094)

Description:
Human PARP1 knockout A549 cell line
Application:
Reactivity:
Conjugate:

Human PML (PML Protein) knockout A549 cell line (ab276096)

Description:
Human PML (PML Protein) knockout A549 cell line
Application:
Reactivity:
Conjugate:

Human PML+RARA Fusion peptide (ab46898)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human PRDM14 peptide (ab103275)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human PRMT8 peptide (ab73685)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human RUNX2 knockout K-562 cell line (ab277898)

Description:
RUNX2 KO K-562 cell line
Application:
Reactivity:
Conjugate:

Human SALL1 peptide (ab31904)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human SOX1 peptide (ab30608)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human SOX9 peptide (ab27845)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated
  • ‹
  • 1
  • 2
  • ...
  • 904
  • 905
  • 906
  • 907
  • 908
  • 909
  • 910
  • ...
  • 919
  • 920
  • ›
Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.